尊龙凯时 - 人生就是搏!

• About
  About Us

  Leadership

  Scientific Advisory Board

  Locations

  Development History

  Awards

  Investor

  Announcements

  Stock Trend

  Investor Interaction

  ESG

  ESG Concept

  ESG Policy

  Media Center

  Video Center

  Image Center
• Product & Services
  API & Intermediate

  Portfolio

  R&D

  Patents

  CDMO

  One-Stop Service

  Platforms

  Capacity

  Finished Dosage Form

  Product Service

  R&D

  Aesthetic & Care Ingredients

  Portfolio

  R&D
• Technology Platforms
  DS Technology Platforms

  Flow Chemistry

  Synthetic Biology & Biocatalysis

  Crystallization & Particle Engineering

  Peptide

  High Potency Compound

  Conjugate Library Service

  Oligonucleotide Synthesis

  Preparation & Purification

  DP Technology Platforms

  Controlled-release Formulation Development

  Taste Masking Technology

  Particle Flow Simulation

  Technical Support Centers

  Analytical Testing Center

  Process Safety Center
• News
  Events

  News Room
• Careers
  Join Us

  Meet our People

  Talent Strategy

  Working at Apeloa

CN

Contact Us

• About
  About Us

  Leadership

  Scientific Advisory Board

  Locations

  Development History

  Awards

  Investor

  Announcements

  Stock Trend

  Investor Interaction

  ESG

  ESG Concept

  ESG Policy

  Media Center

  Video Center

  Image Center
• Product & Services
  API & Intermediate

  Portfolio

  R&D

  Patents

  CDMO

  One-Stop Service

  Platforms

  Capacity

  Finished Dosage Form

  Product Service

  R&D

  Aesthetic & Care Ingredients

  Portfolio

  R&D
• Technology Platforms
  DS Technology Platforms

  Flow Chemistry

  Synthetic Biology & Biocatalysis

  Crystallization & Particle Engineering

  Peptide

  High Potency Compound

  Conjugate Library Service

  Oligonucleotide Synthesis

  Preparation & Purification

  DP Technology Platforms

  Controlled-release Formulation Development

  Taste Masking Technology

  Particle Flow Simulation

  Technical Support Centers

  Analytical Testing Center

  Process Safety Center
• News
  Events

  News Room
• Careers
  Join Us

  Meet our People

  Talent Strategy

  Talent Development

  Talent Policy

  Working at Apeloa
• Contact Us
• CN

Contact Us

• About
  About Us

  Investor

  ESG

  Media Center
• Product & Services
  API & Intermediate

  CDMO

  Finished Dosage Form

  Aesthetic & Care Ingredients
• Technology Platforms
  DS Technology Platforms

  DP Technology Platforms

  Technical Support Centers
• News
  Events

  News Room
• Careers
  Join Us

  Meet our People

  Talent Strategy

  Working at Apeloa

Copyright © 2025 APELOA PHARMA All Rights Reserved. Zhe ICP No. 18020454-1

Zhejiang Public Security Network No. 33078302100640 Sitemap

Enterprise Mailbox

Office Automation System

Home

About us

Leadership

Scientific advisory board

Locations

Development History

Awards

API & Intermediate

CDMO

Finished Dosage Form

Aesthetic & Care Ingredients

• DS Technology Platforms
  Flow Chemistry Synthetic Biology & Biocatalysis Highly Potent Compound Peptide TPD/PROTAC Oligonucleotide Synthesis Crystallization & Particle Engineering Preparation & Separation
• DP Technology Platforms
  Controlled-release Formulation Development

  Taste Masking Technology

  Particle Flow Simulation
• Technical Support Centers
  Analytical Testing Center

  Process Safety Center

• Events
  15th COSME Week Tokyo 43rd Annual J.P. Morgan Healthcare Conference CPHI Middle East 2024 41st Medicinal Chemistry Symposium BioEurope 2024 15th World ADC Conference CPHI Milan 2024 CBA Annual Conference 2024 SAPA 2024 Annual Conference 23rd Contract Pharma Conference & Tabletop Exhibition 52nd Organic Process Research and Development Conference ChemOutsourcing 2024 2nd Annual ADC Linker and Conjugation Summit CBA-China 2024 CPHI China 2024 Chemspec Europe 2024 CPHI North America 2024 12th Annual Advances in Chemical Sciences Symposium DCAT Week 2024 51st Organic Process Research & Development Conference 6th Flow Chemistry and Continuous Processing Conference
• News Room
  APELOA proudly introduces our latest API product, Gabapentin APELOA has obtained FDA approval for Amantadine Hydrochloride Tablets (100mg) Grand Opening of the Apeloa Pharma Solutions R&D Center in Billerica, MA Dr. Yong-Li Zhong as Chief Technology Officer, Chemistry 2024 Interim Report Highlights APELOA has obtained FDA approval for our Metoprolol Succinate Extended-Release Tablets Apeloa is among the Top 5 in the China Pharmaceutical CDMO Companies Dr. Johannes Platzek as Chief Scientific Officer of APELOA CDMO BU We are proud to announce that Apeloa has received the "API Development & Innovation Award" and the "Premium Global Partner" award at CPHI China 2024! Hasten Biopharmaceutical Forms Strategic Partnership with Apeloa Pharmaceutical to Enhance Healthcare Innovation Innovation Milestone: Apeloa Pharmaceutical CDMO Global Service Platform Ready for Use, Pharmaceutical Manufacturing Innovation Forum Held

Join us

Meet our People

Talent Strategy

Working at Apeloa